Title : Novel immunotherapy in the treatment of advanced non-small cell lung cancer.

Pub. Date : 2016 Dec

PMID : 27623999






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In patients with NSCLC harboring specific genetic alterations the anti EGFR TKIs and the ALK TKIs have improved the response rate and the quality of life compared to standard platinum-based chemotherapy. Platinum ALK receptor tyrosine kinase Homo sapiens